Journal of the American Chemical Society vs Nature: Which Should You Submit To?

Nature's JIF is 56.1 in the 2026 JCR release, while JACS is 16.6. Nature is about 3.4 times higher by the raw two-year JIF. That does not make Nature the better home for every chemistry paper. It means Nature has a different audience and citation ecology. JACS remains an elite chemistry venue, and for many chemistry-led papers it is the more credible first target.

For career impact, publishing in Nature is career-defining when the paper truly meets Nature's breadth bar. Publishing in JACS is still a major chemistry achievement and can be stronger evidence of field-native chemistry excellence. The prestige gap is real, but the bigger submission risk is choosing Nature for a paper whose best readers are still chemists.

Nature accepts only papers that represent major conceptual advances or paradigm shifts across all sciences. The question is explicit: "Will this fundamentally reshape the field?" Approximately 94% of submissions are rejected, often without peer review. Nature editors are gatekeepers with extraordinarily high bars.

JACS has a high bar but is more focused on chemistry excellence. JACS looks for papers representing significant chemical discoveries - novel reactions, catalysts, materials, understanding of chemical mechanisms - that advance the field. The question is: "Does this represent a major chemical advance?" A paper does not need to be a paradigm shift across all sciences; it needs to be field-defining within chemistry. Approximately 93-95% of submissions are rejected.

In practice: a discovery of a new catalytic reaction that enables previously impossible transformations would be excellent for JACS and might work at Nature if it has broad implications beyond chemistry. A new synthetic strategy that revolutionizes how chemists approach certain problems is JACS material and unlikely to interest Nature (unless it has biomedical applications that reshape medicine). A fundamental discovery about chemical bonding or reactivity that changes how all chemists think about molecular systems would be strong for both but would likely favor Nature.

Choose JACS when the methods, controls, supplementary characterization, references, and cover letter all point to a chemistry-first contribution. The paper can still be ambitious. It just needs to win by chemical significance: a better reaction logic, deeper mechanism, new material behavior, stronger molecular explanation, or field-moving characterization package.

Choose Nature when the title, abstract, first figure, and cover letter make non-chemists care immediately. The chemistry should not be only the technique. It should unlock a biological, physical, energy, materials, environmental, or planetary-science conclusion that another field would recognize as important.

Nature: ~6% acceptance rate. Extremely selective.

JACS: ~8% acceptance rate in current Manusights canonical data. It is still extremely selective, but slightly more accessible than Nature.

Both journals have low acceptance rates. Odds of success are low at both venues, but you have somewhat better odds at JACS if the work is excellent chemistry with specialist rather than broad scientific appeal.

Nature: 8 days median to first editorial decision on the current Nature journal metrics page.

JACS: ACS reports 29.1 days to first peer-review decision. Desk outcomes can come faster, but use the publisher metric as the current public benchmark.

If publication speed is the main constraint, the real comparison is not simply "which journal is faster." Nature is faster at first editorial triage, while JACS can be the more efficient route when the chemistry fit is obvious and the Nature breadth case would be weak.

Nature: Articles are typically 6-8 pages (including figures and methods). Brief, focused presentation required.

JACS: Articles are typically 10-15 pages or longer. JACS allows for more methodological detail and extensive supplementary information.

If your work requires extensive explanation of synthesis, characterization, or mechanistic detail, JACS's longer format is more accommodating. Nature requires extreme conciseness.

Do not choose between JACS and Nature from the APC line alone. Both journals have subscription routes and open-access options or agreements that can change what your lab actually pays. Verify current charges and institutional coverage during the submission workflow.

The editorial decision should come first: if the manuscript is not a Nature-level cross-science story, a lower or waived OA bill will not make Nature the right first target. If the paper is genuinely broad enough for Nature, do not downgrade to JACS only because the chemistry audience feels safer.

Nature editors are highly selective gatekeepers. Most rejections happen at the desk stage. If your paper passes editorial screening, peer review is rigorous. Reviewer feedback is typically brief and focused on confirming significance.

JACS editors are chemistry experts who are slightly more inclusive. More papers go to peer review at JACS than at Nature. Reviewer feedback tends to be detailed and constructive, even for papers that are ultimately rejected. You're more likely to receive actionable comments at JACS.

Paradigm-shifting discovery with implications across sciences: Try Nature first. If your chemistry work will reshape biology or medicine or physics, Nature is appropriate. JACS is your fallback if Nature rejects.

Major chemical discovery with impact primarily in chemistry: JACS is the better target. Your work doesn't need to appeal to non-chemists; it needs to be excellent chemistry. You have similar odds as Nature but are judged by chemistry standards specifically.

Novel catalyst, reaction, or materials discovery: JACS is the logical home. These are classic JACS papers. Nature will likely desk-reject unless your discovery has implications beyond chemistry (e.g., enables a new drug class).

Mechanistic understanding or fundamental chemistry advance: JACS for work that's important to chemists. Nature if the insight reshapes understanding broadly.

Looking for slightly better publication odds: JACS fractionally edges out Nature. Your odds are marginally better at JACS if the work is excellent chemistry.

Common approach: If you believe your chemistry work is truly paradigm-shifting, submit to Nature. If Nature desk-rejects (likely), immediately submit to JACS. The chemistry community will recognize it regardless of the journal, and JACS publication will still be prestigious.

Alternatively, if you're confident the work is excellent chemistry but uncertain about paradigm-shifting status, go directly to JACS. You'll get a fair evaluation and likely receive detailed feedback.

JACS and Nature are both elite journals serving different scopes. Nature is the absolute pinnacle of prestige, requiring paradigm-shifting discovery with broad impact. JACS is the top chemistry journal, requiring field-defining chemistry. Both will deeply strengthen your CV. Publishing in JACS is not "settling" - it's a top-tier achievement in chemistry. The choice depends on whether your work transcends chemistry (Nature) or is a major advance primarily for chemists (JACS).

In most cases, excellent chemistry belongs at JACS. Save Nature submissions for work with genuinely broad interdisciplinary impact.

If you want a clear read on whether your chemistry paper is framed for Nature or better suited to JACS, a JACS vs. Nature scope alignment check checks scope alignment and likely reviewer concerns before you submit.

For manuscripts targeting both JACS and Nature, three patterns generate the most consistent mismatch decisions among the papers we analyze.

Chemistry papers submitted to Nature that are strong but not paradigm-shifting. Nature's author guidelines state that the journal publishes "research of outstanding scientific importance." In our pre-submission review work, we see the word "outstanding" interpreted too generously. A new reaction methodology that is genuinely field-defining for synthetic chemists, a discovery that will reshape how chemists approach a class of transformations, this is JACS material.

A discovery that changes how all scientists, not just chemists, think about molecular reactivity or bonding, this is Nature material. The distinction is whether the advance is important to chemists or important to scientists broadly. Most chemistry papers belong at JACS.

Nature papers submitted to JACS that undersell the cross-disciplinary impact. We observe the opposite pattern: chemistry discoveries with direct implications for biology, medicine, or materials science being submitted to JACS because the authors consider it the "safe" chemistry option.

A new chemical probe that enables a previously impossible measurement in live cells, a synthetic route that makes a class of drug candidates accessible at scale, these papers have broader significance than JACS's chemistry-first editorial lens rewards. Nature Chemistry or Nature itself would evaluate these papers at their full cross-disciplinary value.

Cover letters that fail to distinguish between chemistry importance and scientific importance. The cover letter decision point matters more at Nature than at JACS. We find that manuscripts sent to Nature with cover letters that argue chemistry significance rather than scientific significance are desk-rejected quickly. Nature editors ask whether the finding reshapes understanding across fields. A cover letter that says "this work is important for synthetic chemistry" is a JACS cover letter, not a Nature cover letter.

If you are submitting to Nature, the cover letter must argue that physicists, biologists, or engineers will also need to update their thinking.

SciRev author-reported data confirms JACS's 21-day median to first decision versus Nature's 7-day median. A JACS vs. Nature significance positioning check can help you assess whether your paper's significance argument is positioned correctly for JACS or Nature before you commit.